Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Hansen

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The American Journal of Sports Medicine|July 18, 2012
The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cellsAugustus D Mazzocca, Mary Beth R McCarthy, David M Chowaniec, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonistsAndrew M K Pennell, James B Aggen, Subhabrata Sen, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2016
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance ProfileManuel Tsiang, Gregg S Jones, Joshua Goldsmith, et al.
Nature|December 7, 2021
Long-acting capsid inhibitor protects macaques from repeat SHIV challengesSamuel J Vidal, Elena Bekerman, Derek Hansen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 25, 2014
Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed miceKristen A Baltgalvis, Kathy White, Wei Li, et al.
Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2014
Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunctionIra J Smith, Guillermo L Godinez, Baljit K Singh, et al.
Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.
Nature|July 3, 2020
Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The American Journal of Sports Medicine|July 18, 2012
The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cellsAugustus D Mazzocca, Mary Beth R McCarthy, David M Chowaniec, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonistsAndrew M K Pennell, James B Aggen, Subhabrata Sen, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2016
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance ProfileManuel Tsiang, Gregg S Jones, Joshua Goldsmith, et al.
Nature|December 7, 2021
Long-acting capsid inhibitor protects macaques from repeat SHIV challengesSamuel J Vidal, Elena Bekerman, Derek Hansen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 25, 2014
Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed miceKristen A Baltgalvis, Kathy White, Wei Li, et al.
Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2014
Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunctionIra J Smith, Guillermo L Godinez, Baljit K Singh, et al.
Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.
Nature|July 3, 2020
Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.
Pageof 2